Early research (Phase 1)Looking for participantsNCT07328451
What this trial is testing
Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease
Who this might be right for
Alzheimer Disease, Early Onset
Denali Therapeutics Inc. 68